SS
Salim Syed Mizuho Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Cytokinetics
CYTK
$6.34B
| $53.01 | $84 |
58%
upside
| Outperform | 3 months ago |
|
2
Biogen
BIIB
$20.6B
| $140.67 | $169 |
20%
upside
| Outperform | 4 months ago |
|
3
Amgen
AMGN
$153B
| $283.64 | $280 |
1%
downside
| Neutral | 4 months ago |
|
4
Gilead Sciences
GILD
$143B
| $115.05 | $117 |
2%
upside
| Outperform | 4 months ago |
|
5
Wave Life Sciences
WVE
$1.32B
| $8.29 | $22 |
165%
upside
| Outperform | 9 months ago |
|
6
Vaxcyte
PCVX
$4.29B
| $33.02 | $163 |
394%
upside
| Outperform | 1 year ago |
|
7
Enliven Therapeutics
ELVN
$1.19B
| $20.15 | $34 |
69%
upside
| Buy | 1 year ago |
|
8
CRISPR Therapeutics
CRSP
$4.99B
| $54.86 | $99 |
80%
upside
| Buy | 1 year ago |
|
9
BridgeBio Pharma
BBIO
$10.2B
| $53.38 | $53 |
1%
downside
| Buy | 1 year ago |
|